EP1796703A4 - Composition sans excipient pour le traitement de l'onychomycose - Google Patents

Composition sans excipient pour le traitement de l'onychomycose

Info

Publication number
EP1796703A4
EP1796703A4 EP04789085A EP04789085A EP1796703A4 EP 1796703 A4 EP1796703 A4 EP 1796703A4 EP 04789085 A EP04789085 A EP 04789085A EP 04789085 A EP04789085 A EP 04789085A EP 1796703 A4 EP1796703 A4 EP 1796703A4
Authority
EP
European Patent Office
Prior art keywords
onychomycosis
excipient
treatment
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP04789085A
Other languages
German (de)
English (en)
Other versions
EP1796703A1 (fr
Inventor
Nair G Muraleedharan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Michigan State University MSU
Original Assignee
Michigan State University MSU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michigan State University MSU filed Critical Michigan State University MSU
Publication of EP1796703A1 publication Critical patent/EP1796703A1/fr
Publication of EP1796703A4 publication Critical patent/EP1796703A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
EP04789085A 2004-09-24 2004-09-24 Composition sans excipient pour le traitement de l'onychomycose Withdrawn EP1796703A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/031630 WO2006036144A1 (fr) 2004-09-24 2004-09-24 Composition sans excipient pour le traitement de l'onychomycose

Publications (2)

Publication Number Publication Date
EP1796703A1 EP1796703A1 (fr) 2007-06-20
EP1796703A4 true EP1796703A4 (fr) 2009-07-01

Family

ID=36119190

Family Applications (1)

Application Number Title Priority Date Filing Date
EP04789085A Withdrawn EP1796703A4 (fr) 2004-09-24 2004-09-24 Composition sans excipient pour le traitement de l'onychomycose

Country Status (4)

Country Link
EP (1) EP1796703A4 (fr)
JP (1) JP2008514596A (fr)
CA (1) CA2581606A1 (fr)
WO (1) WO2006036144A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1036661C2 (en) 2009-03-04 2010-09-07 Serrix B V Anti-fungal compounds & compositions.
DE202010012041U1 (de) 2010-08-31 2010-11-18 Sanderstrothmann Gmbh Zubereitung zur Nagelpflege
CN103893599A (zh) * 2014-04-12 2014-07-02 张军 一种治疗灰指甲的外用中药洗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04154719A (ja) * 1990-10-19 1992-05-27 Hiroshi Kikuchi 水虫薬
AU3221497A (en) * 1997-05-30 1998-12-30 Procter & Gamble Company, The Disinfecting compositions and processes for disinfecting surfaces
JP2000128800A (ja) * 1998-10-16 2000-05-09 Hideyo Yamaguchi 水虫の感染予防および／又は治療法およびその器材
US6344190B1 (en) * 1999-02-08 2002-02-05 Board Of Trustees Of Michigan State University Method and compositions for treatment of fungal nail disease
US6436424B1 (en) * 2000-03-20 2002-08-20 Biosphere Medical, Inc. Injectable and swellable microspheres for dermal augmentation
JP2003073290A (ja) * 2001-08-31 2003-03-12 Kao Corp 外用剤組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
RAMSEWAK RUSSEL S ET AL: "In vitro antagonistic activity of monoterpenes and their mixtures against 'toe nail fungus' pathogens.", PHYTOTHERAPY RESEARCH : PTR APR 2003, vol. 17, no. 4, April 2003 (2003-04-01), pages 376 - 379, XP002527754, ISSN: 0951-418X *
ROBERTS D T ET AL: "Guidelines for treatment of onychomycosis.", BRITISH JOURNAL OF DERMATOLOGY, vol. 148, no. 3, March 2003 (2003-03-01), pages 402 - 410, XP002527755, ISSN: 0007-0963 *
See also references of WO2006036144A1 *

Also Published As

Publication number Publication date
WO2006036144A1 (fr) 2006-04-06
AU2004323577A1 (en) 2006-04-06
CA2581606A1 (fr) 2006-04-06
EP1796703A1 (fr) 2007-06-20
JP2008514596A (ja) 2008-05-08
WO2006036144A8 (fr) 2007-06-14

Similar Documents

Publication Publication Date Title
EP1727530A4 (fr) Formulations topiques pour le traitement d'etats dermatologiques
EP1951272A4 (fr) Utilisation de lactobacillus pour le traitement d'infections virales
FR13C0029I2 (fr) Compositions pour le traitement de troubles gastro-intestinaux
FR2854074B1 (fr) Utilisation de l'ivermectine pour le traitement de desordres dermatologiques
FR2871696B1 (fr) Composition topique pour le traitement du psoriasis
EP1628530A4 (fr) Procedes et compositions pour la prevention et le traitement de la sepsie
EP1438062A4 (fr) Methodes et compositions pour le traitement de lesions cutanees
EP2376091A4 (fr) Nouvelles cibles pour le traitement de l'hypercholestérolémie
DK1446122T5 (da) Anvendelse af flibanserin til behandling af uregelmæssigheder ved könsdriften
EP1631271A4 (fr) Methodes et compositions pour distribuer des butanes catecholiques pour le traitement de tumeurs
EP1601251A4 (fr) Compos s pour le traitement de troubles m taboliques
EP1534074A4 (fr) Polytherapie pour le traitement de l'obesite
EP2021110A4 (fr) Préparations solides multifonctionnelles pour traitement de l'eau
EP1804787A4 (fr) Composition flavonoide pour le traitement des maladies bucco-dentaires
PT1321135E (pt) Composicao para o tigimento de oxidacao das fibras ceratinicas
FR2887450B1 (fr) Ingredient concentre pour le traitement et/ou la modification de surfaces, et son utilisation dans des compositions cosmetiques
EP2140882A4 (fr) Agent pour le traitement d'une maladie pulmonaire
FR2860154B1 (fr) Composition pour le traitement de la mauvaise haleine
EP1664011A4 (fr) Compositions ophtalmiques pour le traitement de l'hypertension oculaire
EP1749532A4 (fr) Médicament pour la guérison ou le traitement d'une blessure
EP1581243A4 (fr) Lactoferrine orale pour le traitement des sepsies
EP1750513A4 (fr) Utilisation de ligands gpcr54 pour le traitement de l'infertilite
FR2835851B1 (fr) Composition pour le traitement d'alliages de magnesium
EP2015741A4 (fr) Inhibiteurs de l'histone desacétylase pour le traitement de la neurodégénération
FR2800614B1 (fr) Composition pour le traitement des infections des voies respiratoires

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070404

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090602

17Q First examination report despatched

Effective date: 20090811

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110712